🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We're so proud to hang this up :)

Le diabète de type 2 est un facteur de risque de développer une forme grave de #Covid19. Identifier les marqueurs immunitaires et inflammatoires associés à ces formes sévères permet une prise en charge plus adaptée et plus précoce ➡️bit.ly/2FK2Zvu

Hey!!Know what? Our new paper: "Interferon Regulatory Factor 5 represses oxidative respiration in human and murine macrophages by inhibition of mitochondrial matrix protein GHITM" is now on preprint here --> researchsquare.com/article/rs-477… #IRF5 #Macrophages #Mitochondria

Hi everyone! Christmas has never been so close, so it's time to give you our gift: a postdoctoral position in our Team! #immediab #INEM #PostDoc #Type2Diabetes #Motivation

INEM NECKER is delighted to welcome Dr. Nicolas Venteclef Nicolas Venteclef, an internationally renowned expert in immunometabolism working on macrophages and type 2 diabetes, as new Group Leader, bringing considerable strength to our fundamental and translational activities.

Move completed! Good bye @CRCordeliers ! Thanks for these years of work and conviviality!

Hello INEM NECKER, we just move in ! Nice to meet you!! 🤗🤗

Hommage au Pr Ronan Roussel pro.inserm.fr/hommage-a-rona…

INEM NECKER congratulates its laureates of the 2022 ANR call: fabiola.terzi, @sacripantone, GOFFIN Lab, @MorelLab4, Lida Katsimpardi, JD, Elise Dalmas , Muriel Girard, Nicolas Dupont, Maria Leite de Moraes, Franck Oury, Simon Fillatreau Dr Jamet et Vargas Lab

The Ph.D. project will be conducted between🇱🇺&🇫🇷, is at the intersection of immunology, epidemiology & data science, and is based on Communauté SFDT1 to study type 1 diabetes. Supervised by myself (LIH_Luxembourg), Jean-Pierre Riveline & Dr. Fawaz Alzaid (Inserm) Please RT #t1d

Up next is Nicolas Venteclef to give an overview of their works on immunity and metabolism in diabetes 🔬IMMEDIAB Lab #science #diabetes #research

Great poster-pitch from Aude Jallon at the EMDS2023@VIB conference: meet the pancreatic macrophages!! 🙌🏻

#IRF5 risk variants are associated with #ChronicKidneyDisease Super psyched to be part of this work of art by the indomitable Frederic Fumeron and the IMMEDIAB Lab nature.com/articles/s4143…

Julla & colleagues provide evidence that the assessment of #blood #monocyte frequency & count is a valuable predictive marker for risk of #cardiovascular events in patients with #T2D. Learn more at ahajrnls.org/3SCK4VP Nicolas Venteclef Dr. Fawaz Alzaid

📢We're hiring! Join me INEM NECKER and IMMEDIAB Lab for an amazing #postdoc opportunity to work on #mitochondria and #immunology of liver disease! #ApplyToday ❗️ DM me for more info!

!! We are looking for a macrophage lover postdoc !! 🔬